Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000538600 | SCV000642472 | likely pathogenic | Dilated cardiomyopathy 1G | 2017-01-24 | criteria provided, single submitter | clinical testing | This sequence change deletes 4 nucleotides from exon 326 of the TTN mRNA (c.85589_85592delAATA), causing a frameshift at codon 28530. This creates a premature translational stop signal (p.Lys28530Metfs*7) and is expected to result in a disrupted protein product. This variant is found in the A-band of this gene. While this particular variant has not been reported in the literature, truncating variants in the A-band of TTN are significantly overrepresented in patients with dilated cardiomyopathy and are considered to be likely pathogenic for the disease (PMID: 25589632). For these reasons, this variant has been classified as Likely Pathogenic. |
Labcorp Genetics |
RCV001379487 | SCV001577298 | likely pathogenic | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-01-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Likely Pathogenic. This variant is found in the A-band of this gene. While this particular variant has not been reported in the literature, truncating variants in the A-band of TTN are significantly overrepresented in patients with dilated cardiomyopathy and are considered to be likely pathogenic for the disease (PMID: 25589632). This sequence change deletes 4 nucleotides from exon 326 of the TTN mRNA (c.85589_85592delAATA), causing a frameshift at codon 28530. This creates a premature translational stop signal (p.Lys28530Metfs*7) and is expected to result in a disrupted protein product. |